22 | Growth InhibitorsIBA
01/2018
-
09/2002 |
9 | ProdrugsIBA
09/2013
-
08/2002 |
8 | Phosphates (Orthophosphate)IBA
09/2013
-
06/2002 |
8 | fosbretabulin (combretastatin A4)IBA
03/2012
-
06/2002 |
6 | narciclasineIBA
12/2012
-
01/2003 |
6 | TubulinIBA
07/2011
-
02/2004 |
5 | combretastatinIBA
09/2009
-
09/2008 |
4 | dolastatin 10IBA
01/2017
-
08/2005 |
4 | cephalostatin IIBA
05/2015
-
12/2003 |
4 | isocarbostyrilIBA
12/2012
-
08/2003 |
4 | combretastatin A-1IBA
07/2011
-
02/2004 |
4 | StilbenesIBA
09/2009
-
06/2002 |
4 | Anti-Bacterial Agents (Antibiotics)IBA
03/2009
-
03/2004 |
3 | Antineoplastic Agents (Antineoplastics)IBA
06/2012
-
07/2005 |
3 | pancratistatinIBA
04/2012
-
12/2002 |
3 | ResveratrolIBA
09/2009
-
06/2002 |
3 | SaltsIBA
03/2008
-
01/2003 |
3 | AminesIBA
01/2006
-
02/2003 |
2 | quinstatinIBA
01/2018
-
01/2017 |
2 | quinolineIBA
01/2017
-
05/2011 |
2 | TriterpenesIBA
01/2016
-
04/2014 |
2 | bryostatin 1IBA
04/2015
-
09/2003 |
2 | DiterpenesIBA
03/2013
-
09/2004 |
2 | narcistatinIBA
12/2012
-
01/2003 |
2 | SodiumIBA
12/2012
-
06/2002 |
2 | PyrazinesIBA
06/2012
-
09/2011 |
2 | SesquiterpenesIBA
07/2010
-
03/2010 |
2 | ethyl acetateIBA
07/2010
-
03/2010 |
2 | 7-deoxy-trans-dihydronarciclasineIBA
07/2009
-
01/2006 |
2 | DepsipeptidesIBA
03/2009
-
07/2007 |
2 | majusculamide CIBA
03/2008
-
07/2005 |
2 | phorboxazole AIBA
02/2008
-
02/2006 |
2 | AmidesIBA
08/2005
-
02/2003 |
2 | dolastatin 11IBA
07/2005
-
12/2002 |
2 | FlavonoidsIBA
01/2005
-
02/2003 |
2 | aaptamineIBA
03/2004
-
03/2004 |
2 | Protein Kinase CIBA
09/2003
-
09/2002 |
1 | cephalostatin 20IBA
06/2015 |
1 | Phorbol EstersIBA
04/2015 |
1 | BryostatinsIBA
04/2015 |
1 | neristatin 1IBA
04/2015 |
1 | LactonesIBA
04/2015 |
1 | dolastatin 16IBA
03/2015 |
1 | betulinIBA
04/2014 |
1 | lupaneIBA
04/2014 |
1 | 2- (3'- hydroxy- 4'- methoxyphenyl)- 3- (3'',4'',5''- trimethoxybenzoyl)- 6- methoxyindoleIBA
09/2013 |
1 | indoleIBA
09/2013 |
1 | Phenol (Carbolic Acid)FDA Link
09/2013 |
1 | FormamidesIBA
03/2013 |
1 | pyrimidineIBA
03/2013 |
1 | agelasine FIBA
03/2013 |
1 | CytokinesIBA
12/2012 |
1 | PyronesIBA
06/2012 |
1 | 3-epipancratistatinIBA
04/2012 |
1 | Diphosphates (Pyrophosphates)IBA
07/2011 |
1 | auristatinIBA
05/2011 |
1 | sodium phosphate (trisodium phosphate)FDA LinkGeneric
05/2011 |
1 | coprinastatin 1IBA
03/2010 |
1 | coprinolIBA
03/2010 |
1 | auristatin PYEIBA
03/2010 |
1 | lateritinIBA
03/2010 |
1 | Cisplatin (Platino)FDA LinkGeneric
03/2010 |
1 | papilistatinIBA
02/2010 |
1 | 1,7,9,11- tetrahydroxy- 3- methyl- 8,13- dioxo- 5,6,8,13- tetrahydrobenzo(a)tetracene- 2- carboxylic acid (G-2A)IBA
09/2009 |
1 | stilstatin 3IBA
09/2009 |
1 | dihydronarciclasineIBA
07/2009 |
1 | stilstatin 2IBA
03/2009 |
1 | quinone (benzoquinone)IBA
03/2009 |
1 | combretastatin A-2IBA
03/2009 |
1 | stilstatin 1IBA
03/2009 |
1 | N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
01/2009 |
1 | Prolyl OligopeptidasesIBA
01/2009 |
1 | N-benzyloxycarbonylprolylprolinalIBA
01/2009 |
1 | tasidotinIBA
01/2009 |
1 | (Z)- 2- (4'- methoxy- 3'- aminophenyl)- 1- (3,4,5- trifluorophenyl)etheneIBA
09/2008 |
1 | PhenazinesIBA
09/2008 |
1 | axinastatin 5IBA
03/2008 |
1 | compound 17IBA
03/2008 |
1 | jasplakinolideIBA
03/2008 |
1 | manzamine AIBA
03/2008 |
1 | neoechinulin AIBA
03/2008 |
1 | Alkynes (Acetylenes)IBA
02/2008 |
1 | Alkenes (Olefins)IBA
02/2008 |
1 | AlkanesIBA
02/2008 |
1 | 22-epicalamistrinIBA
01/2008 |
1 | Chalcone (Benzalacetophenone)IBA
01/2008 |
1 | respirantinIBA
07/2007 |